BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 23, 2026
See today's BioWorld
Home
» HHS, FDA ready to open U.S. door to Rx importation
To read the full story,
subscribe
or
sign in
.
HHS, FDA ready to open U.S. door to Rx importation
Aug. 1, 2019
By
Mari Serebrov
U.S. Health and Human Services (HHS) Secretary Alex Azar announced Wednesday that HHS and the FDA are finally opening a door Congress provided decades ago to allow prescription drugs to be imported from Canada.
BioWorld